AVDL
Avadel Pharmaceuticals
AVDL
AVDL
81 hedge funds and large institutions have $230M invested in Avadel Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $259M → $230M (-$28.8M)
13% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 23
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
81
Holding in Top 10
1
Calls
$5.48M
Puts
$2.56M
Top Buyers
| 1 | +$7.65M | |
| 2 | +$3.96M | |
| 3 | +$2.78M | |
| 4 |
GJL
Gendell Jeffrey L
|
+$2.67M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$2.66M |
Top Sellers
| 1 | -$7.69M | |
| 2 | -$3.56M | |
| 3 | -$1.54M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.29M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1M |